XTX Topco Ltd

Position in ADCT — ADC Therapeutics SA

CIK 1828301 LONDON, X0

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$150,164

+$84,832 QoQ

Shares Held

140,341

+705.5% QoQ

Ownership

0.110%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 113 holders

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $78,752,334 across 60 Drug Manufacturers - Specialty & Generic names. ADCT ranks #39 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	193,067	$13,873,794
2	VTRS	Viatris Inc	630,996	$10,020,216
3	UTHR	UNITED THERAPEUTICS Corp	13,055	$7,073,590
4	ELAN	Elanco Animal Health Inc	204,521	$5,033,261
5	NBIX	Neurocrine Biosciences Inc	27,124	$4,571,478
6	HIMS	Hims & Hers Health, Inc.	117,664	$4,079,410
7	PRGO	PERRIGO Co plc	275,509	$2,862,538
8	ALKS	Alkermes plc.	50,788	$2,661,291

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$150,164	140,341	+705.5%	Shares	Defined	2026-08-14
2026-03-31	$65,332	17,422	-79.0%	Shares	Defined	2026-05-15
2025-12-31	$292,534	82,871	-9.5%	Shares	Defined	2026-02-17
2025-09-30	$366,316	91,579	-20.4%	Shares	Defined	2025-11-14
2024-09-30	$362,479	115,073	+102.4%	Shares	Defined	2024-11-14
2024-06-30	$179,687	56,863	+129.0%	Shares	Defined	2024-08-12
2024-03-31	$111,482	24,829	-43.1%	Shares	Defined	2024-05-13
2023-12-31	$72,459	43,650	-34.9%	Shares	Defined	2024-02-13
2023-09-30	$60,144	67,051	-67.5%	Shares	Defined	2023-11-13
2023-06-30	$443,689	206,367	-22.5%	Shares	Defined	2023-08-14
2023-03-31	$519,205	266,259	+34.7%	Shares	Defined	2023-05-12
2022-12-31	$758,918	197,635	+1806.2%	Shares	Defined	2023-02-14
2022-09-30	$49,973	10,368	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.